http://orcid.org/0000-0001-5843-9399
References
- Society for Maternal-Fetal Medicine (SMFM). Electronic address: [email protected], Mari G, Norton ME, et al. Clinical Guideline #8: the fetus at risk for anemia–diagnosis and management. Am J Obstet Gynecol. 2015;212(6):697–710.
- Papantoniou N, Sifakis S, Antsaklis A. Therapeutic management of fetal anemia: review of standard practice and alternative treatment options. J Perinat Med. 2013;41(1):71–82.
- Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med. 2000;342(1):9–14.
- Oepkes D, Seaward PG, Vandenbussche FP, et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med. 2006;355(2):156–164.
- Liley AW. Intrauterine transfusion of foetus in haemolytic disease. Br Med J. 1963;2(5365):1107–1109.
- Berkowitz RL, Hobbins JC. Intrauterine transfusion utilizing ultrasound. Obstet Gynecol. 1981;57(1):33–36.
- Rodeck CH, Kemp JR, Holman CA, et al. Direct intravascular fetal blood transfusion by fetoscopy in severe rhesus isoimmunisation. Lancet. 1981;1(8221):625–627.
- Daffos F, Capella-Pavlovsky M, Forestier F. A new procedure for fetal blood sampling in utero: preliminary results of fifty-three cases. Am J Obstet Gynecol. 1983;146(8):985–987.
- Bigelow CA, Cinelli CM, Little SE, et al. Percutaneous umbilical blood sampling: current trends and outcomes. Eur J Obstet Gynecol Reprod Biol. 2016;200:98–101.
- Schumacher B, Moise KJ. Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol. 1996;88(1):137–150.
- Pasman SA, Claes L, Lewi L, et al. Intrauterine transfusion for fetal anemia due to red blood cell alloimmunization: 14 years experience in Leuven. Facts Views Vis Obgyn. 2015;7(2):129–136.
- van Kamp IL, Klumper FJCM, Oepkes D, et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol. 2005;192(1):171–177.
- Tiblad E, Kublickas M, Ajne G, et al. Procedure-related complications and perinatal outcome after intrauterine transfusions in red cell alloimmunization in Stockholm. Fetal Diagn Ther. 2011;30(4):266–273.
- Zwiers C, Lindenburg ITM, Klumper FJ, et al. Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures. Ultrasound Obstet Gynecol. 2017;50(2):180–186.
- Sainio S, Nupponen I, Kuosmanen M, et al. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study. Acta Obstet Gynecol Scand. 2015;94(4):383–390.
- Garabedian C, Rakza T, Thomas D, et al. Neonatal outcome after fetal anemia managed by intrauterine transfusion. Eur J Pediatr. 2015;174(11):1535–1539.
- Lindenburg ITM, van Kamp IL, van Zwet EW, et al. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation. BJOG. 2013;120(7):847–852.
- Stevenson DK, Verter J, Fanaroff AA, et al. Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage. Arch Dis Child Fetal Neonatal Ed. 2000;83(3):F182–F185.
- Lindenburg IT, Smits-Wintjens VE, van Klink JM, et al. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the Lotus study. Am J Obstet Gynecol. 2012;206(2):141.e1–141.e8.
- Janssens HM, de Haan MJ, van Kamp IL, et al. Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonism. J Pediatr. 1997;131(3):373–380.
- Hudon L, Moise KJ Jr, Hegemier SE, et al. Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease. Am J Obstet Gynecol. 1998;179(4):858–863.
- Grab D, Paulus WE, Bommer A, et al. Treatment of fetal erythroblastosis by intravascular transfusions: outcome at 6 years. Obstet Gynecol. 1999;93(2):165–168.
- Doyle LW, Kelly EA, Rickards AL, et al. Sensorineural outcome at 2 years for survivors of erythroblastosis treated with fetal intravascular transfusions. Obstet Gynecol. 1993;81(6):931–935.
- Blue NR, Van Winden KR, Pathak B, et al. Neonatal outcomes by mode of delivery in preterm birth. Am J Perinatol. 2015;32(14):1292–1297.
- Rashid N, Al-Sufayan F, Seshia MM, et al. Post transfusion lung injury in the neonatal population. J Perinatol. 2013;33(4):292–296.
- Smits-Wintjens VEHJ, Rath MEA, van Zwet EW, et al. Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease. Neonatology. 2013;103(2):141–147.